SCHEMBL20652967

SCHEMBL20652967

CC(C)n1c(=O)[nH]c(=O)c2c1nc(-c1cccnc1OCC1CC1)n2Cc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.45
▸ KDM4E B2RXH2 7/20 0.45
▸ KMT2A Q03164 7/20 0.45
▸ MEN1 O00255 5/20 0.45
▸ HTT P42858 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ HPGD P15428 3/20 0.44
▸ MAPT P10636 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ PKM P14618 2/20 0.43
▸ MCL1 Q07820 1/20 0.43
▸ NPSR1 Q6W5P4 5/20 0.42
▸ POLB P06746 2/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ TSHR P16473 2/20 0.41
▸ CXCL8 P10145 1/20 0.41
▸ NOD2 Q9HC29 1/20 0.41
▸ NOD1 Q9Y239 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20653050 0.94 ALDH1A1 (0.40) ALDH1A1KDM4EKMT2AMEN1HTT
SCHEMBL20652772 0.94 ALDH1A1 (0.41) ALDH1A1KDM4EKMT2AMEN1HTT
SCHEMBL20652960 0.93 TP53 (0.42) ALDH1A1KDM4EKMT2AMEN1HTT
SCHEMBL20653055 0.91 MDM2 (0.44) ALDH1A1KDM4EKMT2AMEN1HTT
SCHEMBL20652748 0.90 ALDH1A1 (0.40) ALDH1A1KDM4EKMT2AMEN1HTT
SCHEMBL20653129 0.89 ALDH1A1 (0.40) ALDH1A1KDM4EKMT2AMEN1HTT
SCHEMBL20656030 0.83 ADORA3 (0.41) MAPTUSP1
SCHEMBL20656208 0.82 RAB9A (0.41) ALDH1A1KDM4EKMT2AMEN1HTT
SCHEMBL20652827 0.82 RAB9A (0.41) ALDH1A1KDM4EKMT2AMEN1HTT
SCHEMBL20653072 0.81 ADORA3 (0.42) ALDH1A1KDM4EHTTSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3652176-B1 SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INT (DE) 2021-12-15 — — EP disclosed
US-10329292-B2 Substituted xanthine derivatives BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-06-25 — — US disclosed
WO-2019011802-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-01-17 — — WO disclosed
US-20190016722-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329292-B2 Substituted xanthine derivatives TRPC5, TRPV1, TRPC4 ALDH1A1 1347/4885KDM4E 3884/4885KMT2A 4180/4885
US-20190016722-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES TRPC5, TRPC4, TRPV1 ALDH1A1 1488/4885KDM4E 3789/4885KMT2A 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback